Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Bo Hong

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 9

  1. Predictive biomarkers of pancreatic cancer metastasis: A comprehensive review. Co-author DOI 10.1016/j.cca.2025.120176↗
  2. Single-nucleus RNA sequencing and spatial transcriptomics reveal an immunosuppressive tumor microenvironment related to metastatic dissemination during pancrea… Co-author DOI 10.7150/thno.108925↗
  3. Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer. Co-author DOI 10.3233/cbm-190067↗
  4. Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pa… Co-author DOI 10.3389/fonc.2019.01377↗
  5. B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer. Co-author DOI 10.1016/j.humpath.2017.05.023↗
  6. MicroRNA Expression Profiling of Pancreatic Cancer Cell Line L3.6p1 Following B7-H4 Knockdown. Co-author DOI 10.1159/000485086↗
  7. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases. Co-author DOI 10.18632/oncotarget.12665↗
  8. B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells. First author DOI 10.1007/s00441-013-1640-8↗
  9. [Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer]. Co-author PMID 24167131↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongsen Liu · 2 shared papers, 2025 · strength 0.59
  2. Yun Qian · 2 shared papers, 2025 · strength 0.59
  3. Yun Qian · 5 shared papers, 2016–2019 · strength 0.40
  4. Hangping Yao · 6 shared papers, 2013–2019 · strength 0.38
  5. Qianming Chen · 1 shared paper, 2025 · strength 0.30
  6. Mengting Chen · 1 shared paper, 2025 · strength 0.28
  7. Hong Xu · 1 shared paper, 2025 · strength 0.28
  8. Xiangming Xu · 2 shared papers, 2019 · strength 0.22
  9. Chenyu W Hu · 2 shared papers, 2017–2019 · strength 0.16
  10. Lingwei Shen · 2 shared papers, 2017 · strength 0.13
  11. Wenxuan Wu · 2 shared papers, 2017 · strength 0.13
  12. Ming‐Hai Wang · 1 shared paper, 2019 · strength 0.09
  13. Qi Wang · 1 shared paper, 2017 · strength 0.06
  14. Lihuang Zhang · 1 shared paper, 2013 · strength 0.04
  15. Yun Qian · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.